Search research articles
Contact Us
Filters
Showing results (141-150 of 232) with videos related to
Page
of 24
Sort By:
Archives of Internal Medicine
|
November 25, 1998
Heartburn requiring frequent antacid use may indicate significant illness
M Robinson, D Earnest, S Rodriguez-Stanley, et al.
Annals of Hematology
|
August 15, 2024
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis
Ghaith Abu-Zeinah, Albert Qin, Harinder Gill, et al.
Cancer
|
October 15, 1992
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group B
A B Kornblith, J Anderson, D F Cella, et al.
Seminars in Hematology
|
April 1, 1988
The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma
M Coleman, J O Armitage, M Gaynor, et al.
The Journal of Cell Biology
|
August 15, 2019
Apical polarity proteins recruit the RhoGEF Cysts to promote junctional myosin assembly
Jordan T Silver, Frederik Wirtz-Peitz, Sérgio Simões, et al.
Blood
|
July 1, 1984
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B
A J Gottlieb, V Weinberg, R R Ellison, et al.
Leukemia & Lymphoma
|
April 15, 2003
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013
Richard T Silver, Bercedis L Peterson, Ted P Szatrowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1991
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B
R R Ellison, R Mick, J Cuttner, et al.
Oncology (Williston Park, N.Y.)
|
May 1, 1990
Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trials
A B Kornblith, J Anderson, D F Cella, et al.
Cancer
|
May 1, 1978
Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma
P Maurice, O Glidewell, C Jacquillat, et al.
Page
of 24
Search research articles
Search
Showing results (141-150 of 232) with videos related to
Sort By:
Page
of 24
Archives of Internal Medicine
|
November 25, 1998
Heartburn requiring frequent antacid use may indicate significant illness
M Robinson, D Earnest, S Rodriguez-Stanley, et al.
Annals of Hematology
|
August 15, 2024
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis
Ghaith Abu-Zeinah, Albert Qin, Harinder Gill, et al.
Cancer
|
October 15, 1992
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation. The Cancer and Leukemia Group B
A B Kornblith, J Anderson, D F Cella, et al.
Seminars in Hematology
|
April 1, 1988
The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma
M Coleman, J O Armitage, M Gaynor, et al.
The Journal of Cell Biology
|
August 15, 2019
Apical polarity proteins recruit the RhoGEF Cysts to promote junctional myosin assembly
Jordan T Silver, Frederik Wirtz-Peitz, Sérgio Simões, et al.
Blood
|
July 1, 1984
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B
A J Gottlieb, V Weinberg, R R Ellison, et al.
Leukemia & Lymphoma
|
April 15, 2003
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013
Richard T Silver, Bercedis L Peterson, Ted P Szatrowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1991
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B
R R Ellison, R Mick, J Cuttner, et al.
Oncology (Williston Park, N.Y.)
|
May 1, 1990
Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trials
A B Kornblith, J Anderson, D F Cella, et al.
Cancer
|
May 1, 1978
Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma
P Maurice, O Glidewell, C Jacquillat, et al.
Page
of 24